Immunitybio Inc banner

Immunitybio Inc
F:26CA

Watchlist Manager
Immunitybio Inc Logo
Immunitybio Inc
F:26CA
Watchlist
Price: 6.41 EUR 8.09% Market Closed
Market Cap: €4.4B

Wall St Price Targets

26CA Price Targets Summary
Immunitybio Inc

Wall Street analysts forecast 26CA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 26CA is 2.96 EUR with a low forecast of 2.58 EUR and a high forecast of 3.66 EUR.

Lowest Forecast
Price Target
2.58 EUR
60% Downside
Average Forecast
Price Target
2.96 EUR
54% Downside
Highest Forecast
Price Target
3.66 EUR
43% Downside
Immunitybio Inc Competitors:
Price Targets
VRNS
Varonis Systems Inc
-6% Downside
NN
NextNav Inc
206% Upside
ARDX
Ardelyx Inc
230% Upside
BRI
Britania PCL
4% Upside
RCR
RL Commercial REIT Inc
15% Upside
TCPC
BlackRock TCP Capital Corp
32% Upside

Revenue
Forecast

60% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat
60% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat

Over the last 11 years, the compound annual growth rate for Revenue has been 60%. The projected CAGR for the next 8 years is 68%.

Gross Profit
Forecast

N/A
Past Growth
60% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
60% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 2 years is 60%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 26CA's stock price target?
Price Target
2.96 EUR

According to Wall Street analysts, the average 1-year price target for 26CA is 2.96 EUR with a low forecast of 2.58 EUR and a high forecast of 3.66 EUR.

What is the Revenue forecast for Immunitybio Inc?
Projected CAGR
68%

Over the last 11 years, the compound annual growth rate for Revenue has been 60%. The projected CAGR for the next 8 years is 68%.

What is the Gross Profit forecast for Immunitybio Inc?
Projected CAGR
60%

The compound annual growth rate for Gross Profit over the next 2 years is 60%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett